Loading asset research
Lisata Therapeutics Inc. Common Stock
LSTANasdaq · USD · StocksQuote as of · Exchange session not verified$1.63
-0.61%
Today
LSTA
Loading 1D prices…
Market cap
$14.7M
Volume
111.9K
52w high
$5.0752w low
$0.99Company profile
Lisata Therapeutics Inc. Common Stock
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with range of anti-cancer regimens. Lisata Therapeutics, Inc. was formerly known as Caladrius Biosciences, Inc. and changed its name to Lisata Therapeutics, Inc. in September 2022. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey. As of July 21, 2026, Lisata Therapeutics, Inc. operates as a subsidiary of Kuva Labs, Inc.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Basking Ridge, NJ, United States
Employees
21
Fiscal year end
1231
CIK
320017
Session & valuation
Open$1.72
Previous close$1.64
Day high$1.72
Day low$1.57
30-day avg. volume393.9K
Outstanding shares9M
Diluted EPS-$1.91
Latest annual period
P/E (trailing)-0.85
P/E (forward)-1.41
Price / book1.80
Beta0.94
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| HINDVyome Holdings Inc. Common Stock | $14.5M | $319.7K | -3209.75% | -$4.86 | -1.90% | Buy |
| ADILAdial Pharmaceuticals Inc Common Stock | $14.4M | $0.00 | — | -$11.93 | -18.33% | Buy |
| SCNXScienture Holdings Inc. Common Stock | $14.3M | $431.6K | -9618.03% | -$2.70 | -2.65% | Buy |
| MBRXMoleculin Biotech Inc. Common Stock | $13.9M | $0.00 | — | -$28.42 | -12.47% | Buy |
| DAREDare Bioscience Inc. Common Stock | $13.9M | $1M | -1300.73% | -$1.20 | +0.27% | Buy |